EMAIL THIS PAGE TO A FRIEND

Traffic (Copenhagen, Denmark)

Distinct Temporal Regulation of RET Isoform Internalization: Roles of Clathrin and AP2.


PMID 26304132

Abstract

The RET receptor tyrosine kinase (RTK) contributes to kidney and nervous system development, and is implicated in a number of human cancers. RET is expressed as two protein isoforms, RET9 and RET51, with distinct interactions and signaling properties that contribute to these processes. RET isoforms are internalized from the cell surface into endosomal compartments in response to glial cell line-derived neurotropic factor (GDNF) ligand stimulation but the specific mechanisms of RET trafficking remain to be elucidated. Here, we used total internal reflection fluorescence (TIRF) microscopy to demonstrate that RET internalization occurs primarily through clathrin coated pits (CCPs). Activated RET receptors colocalize with clathrin, but not caveolin. The RET51 isoform is rapidly and robustly recruited to CCPs upon GDNF stimulation, while RET9 recruitment occurs more slowly and is less pronounced. We showed that the clathrin-associated adaptor protein complex 2 (AP2) interacts directly with each RET isoform through its AP2 μ subunit, and is important for RET internalization. Our data establish that interactions with the AP2 complex promote RET receptor internalization via clathrin-mediated endocytosis but that RET9 and RET51 have distinct internalization kinetics that may contribute to differences in their biological functions.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

SAB1306490
ANTI-CD71(C-TERMINAL) antibody produced in rabbit, purified immunoglobulin, buffered aqueous solution
SAB1409600
Anti-RET antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
HPA008356
Anti-RET antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB1408627
Anti-RET antibody produced in rabbit, purified immunoglobulin, buffered aqueous solution
SAB4502622
Anti-RET, C-Terminal antibody produced in rabbit, affinity isolated antibody
SAB2502166
Anti-TFRC (N-terminal) antibody produced in goat, affinity isolated antibody, buffered aqueous solution
HPA028598
Anti-TFRC antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB4200398
Anti-TFRC antibody produced in rabbit, ~1.0 mg/mL, affinity isolated antibody
SAB4700515 Monoclonal Anti-CD71 antibody produced in mouse, clone MEM-75, purified immunoglobulin, buffered aqueous solution
SAB4700520 Monoclonal Anti-CD71 antibody produced in mouse, clone MEM-189, purified immunoglobulin, buffered aqueous solution
WH0001213M5
Monoclonal Anti-CLTC antibody produced in mouse, clone 2E5, purified immunoglobulin, buffered aqueous solution
WH0005979M1
Monoclonal Anti-RET antibody produced in mouse, clone 1A5, purified immunoglobulin, buffered aqueous solution
SAB5300387 Monoclonal Anti-RET antibody produced in mouse, clone 8D10C9, ascites fluid
SAB5300388 Monoclonal Anti-RET antibody produced in mouse, clone 6E4C4, ascites fluid
SAB1404311
Monoclonal Anti-RET, (C-terminal) antibody produced in mouse, clone 1C6, purified immunoglobulin, buffered aqueous solution
SAB1402945
Monoclonal Anti-TFRC antibody produced in mouse, clone 1E6, purified immunoglobulin, buffered aqueous solution